Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Frost

Showing results (261-270 of 301) with videos related to

Pageof 31
Sort By:
Journal of the American College of Cardiology|August 2, 2005
Ambrisentan therapy for pulmonary arterial hypertensionNazzareno Galié, David Badesch, Ronald Oudiz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 1, 2021
Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT studyRaymond L Benza, Athénaïs Boucly, Harrison W Farber, et al.
The International Journal of Neuroscience|October 15, 2010
Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon βMaria Melanson, Amy Grossberndt, Meghann Klowak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 8, 2011
Staphylococcus aureus harbouring Enterotoxin A as a possible risk factor for multiple sclerosis exacerbationsMichael R Mulvey, Malcolm Doupe, Michael Prout, et al.
The European Journal of Neuroscience|October 6, 1999
Myelination and behaviour of tenascin-C null transgenic miceB W Kiernan, E Garcion, J Ferguson, et al.
Chest|September 25, 2008
Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalitiesMichael D McGoon, Adaani E Frost, Ronald J Oudiz, et al.
JAMA Dermatology|July 9, 2020
Quality of Life Assessed Using Skindex-16 Scores Among Patients With Acne Receiving Isotretinoin TreatmentAaron M Secrest, Zachary H Hopkins, Zachary E Frost, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 28, 2017
Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysisMurali M Chakinala, Daniel W Coyne, Raymond L Benza, et al.
Chest|March 12, 2011
Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL RegistryLynette M Brown, Hubert Chen, Scott Halpern, et al.
Sexually Transmitted Infections|October 24, 2003
Sexually transmitted infections in male clients of female sex workers in Benin: risk factors and reassessment of the leucocyte esterase dipstick for screening of urethral infectionsM Alary, C M Lowndes, L Mukenge-Tshibaka, et al.
Pageof 31

Showing results (261-270 of 301) with videos related to

Sort By:
Pageof 31
Journal of the American College of Cardiology|August 2, 2005
Ambrisentan therapy for pulmonary arterial hypertensionNazzareno Galié, David Badesch, Ronald Oudiz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 1, 2021
Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT studyRaymond L Benza, Athénaïs Boucly, Harrison W Farber, et al.
The International Journal of Neuroscience|October 15, 2010
Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon βMaria Melanson, Amy Grossberndt, Meghann Klowak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 8, 2011
Staphylococcus aureus harbouring Enterotoxin A as a possible risk factor for multiple sclerosis exacerbationsMichael R Mulvey, Malcolm Doupe, Michael Prout, et al.
The European Journal of Neuroscience|October 6, 1999
Myelination and behaviour of tenascin-C null transgenic miceB W Kiernan, E Garcion, J Ferguson, et al.
Chest|September 25, 2008
Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalitiesMichael D McGoon, Adaani E Frost, Ronald J Oudiz, et al.
JAMA Dermatology|July 9, 2020
Quality of Life Assessed Using Skindex-16 Scores Among Patients With Acne Receiving Isotretinoin TreatmentAaron M Secrest, Zachary H Hopkins, Zachary E Frost, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 28, 2017
Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysisMurali M Chakinala, Daniel W Coyne, Raymond L Benza, et al.
Chest|March 12, 2011
Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL RegistryLynette M Brown, Hubert Chen, Scott Halpern, et al.
Sexually Transmitted Infections|October 24, 2003
Sexually transmitted infections in male clients of female sex workers in Benin: risk factors and reassessment of the leucocyte esterase dipstick for screening of urethral infectionsM Alary, C M Lowndes, L Mukenge-Tshibaka, et al.
Pageof 31